Power Law company profile

Bicycle Therapeutics

Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2009 · IPO 2019 Unicorn

Therapeutics based on its proprietary bicyclic peptide product platform

Revenue

$73M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

16 investors on Bicycle Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Novartis Venture Fund

Series A 4 investors entered at this stage

Atlas Venture

Astellas Venture

SR One

SV Health Investors

Series B+ 11 investors entered at this stage

EcoR1 Capital

Longwood Fund

Forbion Capital Partners

Perceptive Advisors

Vertex Ventures HC

EPFL Swiss Federal Polytechnic School of Lausanne

Deep Track Capital

RA Capital Management

Fairmount Funds Management

Cambridge Innovation Capital

University of Cambridge

Global footprint

Where Bicycle Therapeutics has talent and traffic

AI talent share

2.8% of workforce is AI talent
(8 of 282 staff)

Core AI20.71%

Other AI62.13%

Non-AI workforce27497.16%

Workforce by country

5 countries with
team presence

🇬🇧 United Kingdom65%

🇺🇸 United States33.5%

🇮🇹 Italy0.4%

🇪🇸 Spain0.4%

🇦🇺 Australia0.4%

5 countries shown

Web traffic by country

10K monthly visits
across markets

🇺🇸 United States46%

🇬🇧 United Kingdom36%

🇯🇵 Japan14%

🇮🇳 India6%

🇫🇷 France1%

Top 5 markets shown

Patent intelligence

$38M patent portfolio · 8 active families

Estimated portfolio value

$38M

20.3× smaller than top peer BioNTech ($780M)

8 active patent families

Where Bicycle Therapeutics innovates Molecular biologyPeptide ligandCarcinosisKallikreinPeptide

Where Bicycle Therapeutics concentrates vs peers

Each axis is a top-10 topic across Bicycle Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Bicycle Therapeutics

An AI-synthesized read of the highest-engagement posts about Bicycle Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bicycle Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles